Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The American Journal of Medicine|September 1, 2001
A comparison of short-term treatment with inhaled fluticasone propionate and zafirlukast for patients with persistent asthmaR A Nathan, E R Bleecker, C Kalberg, et al.
Journal of Neurochemistry|January 1, 1993
The cholinergic stimulating effects of ciliary neurotrophic factor and leukemia inhibitory factor are mediated by protein kinase CC Kalberg, S Y Yung, J A Kessler
The Journal of Allergy and Clinical Immunology|May 10, 2001
Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbationsJ Matz, A Emmett, K Rickard, et al.
Pharmacoeconomics|October 13, 2001
Cost-efficacy analysis of fluticasone propionate versus zafirlukast in patients with persistent asthmaR Menendez, R H Stanford, L Edwards, et al.
Pulmonary Pharmacology & Therapeutics|December 21, 2004
The bronchodilator response to salmeterol is maintained with regular, long-term use in patients with COPDN A Hanania, C Kalberg, J Yates, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 5, 1999
The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study GroupJ J Condemi, S Goldstein, C Kalberg, et al.
The Journal of Allergy and Clinical Immunology|June 9, 1999
Comparison of inhaled salmeterol and oral zafirlukast in patients with asthmaW Busse, H Nelson, J Wolfe, et al.
Medgenmed : Medscape General Medicine|September 11, 2001
Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroidsH S Nelson, R A Nathan, C Kalberg, et al.
Respiratory Medicine|July 9, 2013
Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPDJ F Donohue, M R Maleki-Yazdi, S Kilbride, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 1, 1998
Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthmaS E Wenzel, W Lumry, M Manning, et al.
Pageof 2